← Leaderboards
Graham P Allaway
Celek Pharmaceuticals, Llc
$780,284
Attributed
$780,284
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $449.8K · FY2010–14$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$780,284 · 4
By mechanism
R41$449,754 · 2
R43$330,530 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisEffective TherapyDrug CandidateProgramsMouse ModelProteinsPharmaceutical PreparationsUniversitiesInflammatoryGenesGlutathioneGenetic TranscriptionAsthmaInflammationInhibitor/AntagonistAnti-Inflammatory AgentsBaseDoseEnzymesAnti-InflammatoryClinical TrialsAnimal ModelAdrenal Cortex HormonesCollaborations
Grant awards (4)
Developing a Nrf2 activator for the treatment of COPD$224,896
R41 · FY2014 · HL · contact PI
Developing a Nrf2 activator for the treatment of scleroderma$224,858
R41 · FY2014 · AR · contact PI
Development of small molecules targeting Nrf2 pathway for treatment of Colitis$149,959
R43 · FY2013 · DK · contact PI
Developing a Novel Peptide Therapeutic for Interstitial Cystitis/Painful Bladder$180,571
R43 · FY2010 · DK · contact PI